Tag: euro3.2M

  • dehaze raises €3.2M for AI chronic disease detection

    dehaze, a Munich-based healthtech AI company, has raised €3.2 million in a seed funding round led by YZR Capital and DN Capital, with participation from Angel Invest, Zoho, and Better Ventures. The funding will support the company’s efforts to develop a foundational AI model for chronic disease detection. dehaze’s platform uses causal AI to analyse read more

    dehaze raises €3.2M for AI chronic disease detection